Results 31 to 40 of about 56,937 (260)

Carbapenem-resistant genes primer sets.

open access: yes, 2023
BackgroundCarbapenem-resistant Enterobacteriaceae (CRE) and Extended-spectrum beta-lactamase (ESBL) production among Gram-negative Enterobacteriaceae is an increasing global challenge due to the high morbidity and mortality associated with their ...
Frank Twum Aboagye (17304867)   +3 more
core   +1 more source

Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2020
Consumption of carbapenem has increased due to extended-spectrum beta-lactamase-producing bacteria spreading. Ertapenem has been suggested as a not carbapenem-resistance inducer.
Tiago Zequinão   +3 more
doaj   +1 more source

A systematic review: the current status of carbapenem resistance in East Africa

open access: yesBMC Research Notes, 2018
Objective In this systematic review, we present the molecular epidemiology and knowledge gaps of the carbapenem resistance in East Africa as well as the future probable research interventions that can be used to address the emergence of carbapenem ...
Kenneth Ssekatawa   +3 more
doaj   +1 more source

Carbapenem resistance in extensively drug-resistant Salmonella enterica serovar Agona and AmpC β-lactamase-producing S. Infantis

open access: yesMicrobiology Spectrum, 2023
We report that carbapenem resistance developed in an extensively drug-resistant Salmonella enterica serovar Agona strain during antimicrobial therapy and in an AmpC β-lactamase-producing S. Infantis strain.
Ping-Chun Hsu   +6 more
doaj   +1 more source

Carbapenemase-producing Aeromonas species isolated from the urban-impacted Akaki river in Ethiopia

open access: yesJournal of Water and Health, 2022
Carbapenemase-producing Aeromonas species are an emerging health threat. This study aimed to determine carbapenemase-mediated resistance among Aeromonas isolates from the Akaki river, Ethiopia during the dry and wet seasons in 2019–2020.
Berhanu Yitayew   +6 more
doaj   +1 more source

Characterisation of carbapenem-resistant Gram-negative organisms from clinical specimens in Yola, Nigeria

open access: yesJournal of Global Antimicrobial Resistance, 2020
Objectives: This study aimed to identify carbapenem-resistant Gram-negative bacteria from clinical specimens of patients in Yola, Nigeria. Methods: Routine clinical specimens were screened for the presence of carbapenem-resistant Gram-negative bacteria ...
Shuwaram A. Shettima   +3 more
doaj   +1 more source

Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality

open access: yesInternational Journal of Infectious Diseases, 2017
Objective: The impact of pediatric antimicrobial stewardship programs (ASP) on antimicrobial resistance (AMR) remains largely unknown. This study aimed to evaluate the AMR for carbapenem of Gram-negative bacilli (GNB) and carbapenem use with infectious ...
Yuho Horikoshi   +9 more
doaj   +1 more source

Resistance Pattern of Carbapenem on Enterobacteriaceae

open access: yesJournal of Nepal Medical Association, 2018
Introduction: Gram negative bacilli are the important causes of common clinical infections. Carbapenem resistant Enterobacteriaceae are considered as important public health threat and is classified as urgent by the Centers of Disease Control and Prevention because of their progressive geographic dissemination and limited therapeutic alternatives. This
Khilasa Pokharel   +4 more
openaire   +4 more sources

Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales [PDF]

open access: yes, 2023
The OXA-10 class D β-lactamase has been reported to contribute to carbapenem resistance in non-fermenting Gram-negative bacilli; however, its contribution to carbapenem resistance in Enterobacterales is unknown.
Aja-Macaya, Pablo   +37 more
core   +1 more source

Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Aminoglycosides are the drug of choice for the treatment of Pseudomonas aeruginosa infections. Aminoglycoside resistance in P. aeruginosa often occurred via acquired aminoglycoside-modifying enzymes (AMEs).
Yeliz TANRIVERDİ ÇAYCI   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy